AD
Amie Deakin
Associate Director, Key Accounts at Tg Therapeutics,
View Amie's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Associate Director, Key Accounts
Oct 2022 - Present · 2 years and 3 months
Neurology Integrated Care Manager
Jun 2020 - Oct 2022 · 2 years and 4 months
Executive Sales Representative
Apr 2003 - Mar 2020 · 16 years and 11 months
Company Details
201-500 Employees
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline including several investigational medicines, TG has completed a Phase 3 program for ublituximab, an investigational glycoengineered monoclonal antibody that targets a unique epitope on CD20-expressing B-cells, to treat patients with relapsing forms of multiple sclerosis (RMS).
Year Founded
2011
Social Media
LinkedinFacebookTwitter
Industry
Biotechnology Research
HQ Location
New York, NY 10014, US
Keywords
Biotechnologyhematological malignancieson-Hodgkin's lymphommultiple sclerosisb-cell diseasesublituximabumbralisib
Discover More About Cleveland Clinic

Find verified contacts of Amie Deakin in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.